Technique could help identify patients who would suffer chemo-induced heart damage
Cancer patients who receive a particular type of chemotherapy called doxorubicin run a risk of sustaining severe, lasting heart damage. But it is not possible to predict who is likely to experience this serious side effect. ...
Apr 18, 2016
0
11